@maitxapostol: To be creative means to be in love with life. You can be creative only if you love life enough that you want to enhance it’s beauty, you want to bring a little more music to it, a little more poetry to it, a little more dance to it. #paintingprocess #acrylic #painting #paint #art

maitxart on ig
maitxart on ig
Open In TikTok:
Region: PH
Sunday 23 August 2026 13:03:13 GMT
4267
297
4
3

Music

Download

Comments

leighpadernal
Natsudo :
Dammm
2026-08-23 14:38:54
0
altalunaaa
Mauwe :
😍😍😍
2026-08-23 13:49:57
0
melco47
melco :
🥰🥰🥰
2026-08-23 13:49:17
0
mrnndrthyjnr
Marianne🎨🌱 :
💖🔥🔥🔥🔥
2026-08-23 14:41:05
0
To see more videos from user @maitxapostol, please go to the Tikwm homepage.

Other Videos

The tumor can be removed. Your margins can be clear. Your scans can look good. You may finish chemotherapy and radiation. And then your oncologist says: “Now we start hormone therapy.” For many people with hormone-positive breast cancer, endocrine therapy is recommended for at least 5 years and sometimes up to 10 years, depending on recurrence risk. Why? Because ER-positive cancer cells can use estrogen signaling to grow. Medications such as Tamoxifen, anastrozole, letrozole and exemestane help block estrogen’s effects or dramatically reduce estrogen production. 🌸YOU MAY BE THROWN INTO EARLY MENOPAUSE This isn’t talked about enough. If you’re diagnosed before natural menopause, treatment may suddenly change your hormones. At 42 years old, that can be life-changing. Hot flashes. Night sweats. Sleep problems. Vaginal dryness. Sexual changes. Mood changes. Joint discomfort. Changes in bone health. And you’re dealing with all of this while you’re STILL recovering physically and emotionally from cancer. 🌸 OVARIAN SUPPRESSION OR OVARY REMOVAL MAY BE DISCUSSED For certain premenopausal women with higher-risk hormone-positive breast cancer, doctors may recommend ovarian suppression. Medications such as goserelin or leuprolide can temporarily shut down ovarian estrogen production. Some women may also discuss surgical removal of the ovaries, which permanently causes menopause. These are NOT small decisions. Your age, recurrence risk, fertility wishes, treatment plan and quality of life all matter. 🌸 THE SIDE EFFECTS ARE REAL Sometimes people hear: “You’re cancer-free! You should just be grateful.” We ARE grateful. But gratitude doesn’t make treatment side effects disappear. Hormone therapy can cause: Hot flashes. Joint and muscle pain. Fatigue. Sleep problems. Sexual-health changes. Mood changes. Bone loss with aromatase inhibitors. Some people tolerate these medications very well. Others struggle every single day. If that’s you, tell your oncologist. Sometimes switching medications or treating individual side effects can make a huge difference. You don’t have to silently suffer. 🌸 THE FEAR OF RECURRENCE DOESN’T DISAPPEAR WHEN TREATMENT ENDS This is one of the hardest realities of ER-positive breast cancer. Hormone-positive breast cancer can have a long-term recurrence risk, sometimes extending many years beyond the original diagnosis. That does NOT mean your cancer is going to return. Many people are successfully treated and never experience recurrence. But the long-term risk is one reason doctors may recommend years of endocrine therapy. And psychologically? Every unexplained pain can make you wonder. “Is it back?” Every scan can bring anxiety. Every oncology appointment can remind you of the day you were diagnosed. Survivorship isn’t simply going back to the person you were before cancer. Sometimes it’s learning how to live fully while accepting that you can’t control everything. 🤍 BREAST CANCER AWARENESS IS MORE THAN PINK RIBBONS. It’s surgery. It’s chemotherapy for those who need it. It’s radiation. It’s hormone therapy. It’s medically induced menopause. It’s long-term medication. It’s side effects. It’s recurrence anxiety. And it’s learning how to build a life again after cancer changed everything. Hormone-positive breast cancer is highly treatable for many people—but that doesn’t mean the journey is easy. We need to talk about BOTH. The success of modern treatment… AND the reality of living through it. 🤍🎗️ 📚 SOURCES • National Cancer Institute  • National Cancer Institute  • American Cancer Society  • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)  • SOFT & TEXT clinical trials — ovarian suppression in premenopausal hormone-receptor-positive breast cancer #womenshealth #fyp #cancer #breastcancer      ⚠️ Educational only: Treatment and recurrence risk vary significantly from person to person. Never stop or change endocrine therapy without discussing your individual risks, benefits and alternatives with your oncology team.
The tumor can be removed. Your margins can be clear. Your scans can look good. You may finish chemotherapy and radiation. And then your oncologist says: “Now we start hormone therapy.” For many people with hormone-positive breast cancer, endocrine therapy is recommended for at least 5 years and sometimes up to 10 years, depending on recurrence risk. Why? Because ER-positive cancer cells can use estrogen signaling to grow. Medications such as Tamoxifen, anastrozole, letrozole and exemestane help block estrogen’s effects or dramatically reduce estrogen production. 🌸YOU MAY BE THROWN INTO EARLY MENOPAUSE This isn’t talked about enough. If you’re diagnosed before natural menopause, treatment may suddenly change your hormones. At 42 years old, that can be life-changing. Hot flashes. Night sweats. Sleep problems. Vaginal dryness. Sexual changes. Mood changes. Joint discomfort. Changes in bone health. And you’re dealing with all of this while you’re STILL recovering physically and emotionally from cancer. 🌸 OVARIAN SUPPRESSION OR OVARY REMOVAL MAY BE DISCUSSED For certain premenopausal women with higher-risk hormone-positive breast cancer, doctors may recommend ovarian suppression. Medications such as goserelin or leuprolide can temporarily shut down ovarian estrogen production. Some women may also discuss surgical removal of the ovaries, which permanently causes menopause. These are NOT small decisions. Your age, recurrence risk, fertility wishes, treatment plan and quality of life all matter. 🌸 THE SIDE EFFECTS ARE REAL Sometimes people hear: “You’re cancer-free! You should just be grateful.” We ARE grateful. But gratitude doesn’t make treatment side effects disappear. Hormone therapy can cause: Hot flashes. Joint and muscle pain. Fatigue. Sleep problems. Sexual-health changes. Mood changes. Bone loss with aromatase inhibitors. Some people tolerate these medications very well. Others struggle every single day. If that’s you, tell your oncologist. Sometimes switching medications or treating individual side effects can make a huge difference. You don’t have to silently suffer. 🌸 THE FEAR OF RECURRENCE DOESN’T DISAPPEAR WHEN TREATMENT ENDS This is one of the hardest realities of ER-positive breast cancer. Hormone-positive breast cancer can have a long-term recurrence risk, sometimes extending many years beyond the original diagnosis. That does NOT mean your cancer is going to return. Many people are successfully treated and never experience recurrence. But the long-term risk is one reason doctors may recommend years of endocrine therapy. And psychologically? Every unexplained pain can make you wonder. “Is it back?” Every scan can bring anxiety. Every oncology appointment can remind you of the day you were diagnosed. Survivorship isn’t simply going back to the person you were before cancer. Sometimes it’s learning how to live fully while accepting that you can’t control everything. 🤍 BREAST CANCER AWARENESS IS MORE THAN PINK RIBBONS. It’s surgery. It’s chemotherapy for those who need it. It’s radiation. It’s hormone therapy. It’s medically induced menopause. It’s long-term medication. It’s side effects. It’s recurrence anxiety. And it’s learning how to build a life again after cancer changed everything. Hormone-positive breast cancer is highly treatable for many people—but that doesn’t mean the journey is easy. We need to talk about BOTH. The success of modern treatment… AND the reality of living through it. 🤍🎗️ 📚 SOURCES • National Cancer Institute • National Cancer Institute • American Cancer Society • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) • SOFT & TEXT clinical trials — ovarian suppression in premenopausal hormone-receptor-positive breast cancer #womenshealth #fyp #cancer #breastcancer ⚠️ Educational only: Treatment and recurrence risk vary significantly from person to person. Never stop or change endocrine therapy without discussing your individual risks, benefits and alternatives with your oncology team.

About